Clinical Trial

Study of ADSTEM Injection for Patients With Moderate to Severe Subacute and Chronic Atopic Dermatitis

Name: Study of ADSTEM Injection for Patients With Moderate to Severe Subacute and Chronic Atopic Dermatitis — clinical trial record (NCT07377838)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: ADSTEM Inj

Not Yet Recruiting Phase 3

View on ClinicalTrials.gov →

Summary

Study of ADSTEM Injection for Patients with Moderate to Severe Subacute and Chronic Atopic Dermatitis

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2026-01-28.

Trial Details

NCT Number	NCT07377838
Lead Sponsor	EHL Bio Co., Ltd.
Conditions	Atopic Dermatitis
Enrollment	286 participants
Start Date	2026-06
Primary Completion	2029-06 (estimated)
Study Completion	2029-12 (estimated)
Updated on ClinicalTrials.gov	2026-02-12